Primary robot-assisted laparoscopic partial nephrectomy for hemorrhage secondary to angiomyolipoma: a retrospective study from a large tertiary hospital in China
View abstract on PubMed
Summary
This summary is machine-generated.Robot-assisted Laparoscopic Partial Nephrectomy (RALPN) is a safe and effective primary treatment for Hemorrhage secondary to angiomyolipoma (HSA). This minimally invasive approach offers a viable alternative to traditional methods, with manageable complications and successful hemorrhage control.
Area Of Science
- Urology
- Minimally Invasive Surgery
- Oncology
Background
- Angiomyolipoma (AML) can cause significant Hemorrhage (HSA), posing a clinical challenge.
- Robot-assisted Laparoscopic Partial Nephrectomy (RALPN) is emerging as a treatment option for renal masses.
- Primary RALPN for HSA is infrequently reported, necessitating further investigation.
Purpose Of The Study
- To evaluate the efficacy and safety of primary Robot-assisted Laparoscopic Partial Nephrectomy (RALPN) for treating Hemorrhage secondary to angiomyolipoma (HSA).
Main Methods
- Retrospective analysis of fourteen patients who underwent primary RALPN for HSA between 2015 and 2023.
- Preoperative assessment included blood routine and Contrast-enhanced computed tomography (CT) for retroperitoneal hematoma.
- Surgical technique involved transabdominal access, tumor resection, hematoma removal, and closure with absorbable barbed sutures.
Main Results
- All fourteen patients (aged 14-56) achieved successful hemorrhage control with primary RALPN.
- Tumor sizes ranged from 57-145 mm, with RENAL scores between 7-11.
- Postoperative complications were limited to chylous drainage (Clavien-Dindo II) and pleural effusion (Clavien-Dindo III) in one patient each; no transfusions or embolization were required.
Conclusions
- Primary RALPN is a safe and effective surgical option for managing Hemorrhage secondary to angiomyolipoma (HSA).
- This minimally invasive technique provides successful hemorrhage control and avoids the need for postoperative transfusions or embolization.
- RALPN can be considered a valuable alternative to selective renal artery embolization for HSA.

